Perrigo (PRGO) Net Cash Flow (2013 - 2026)
Perrigo (PRGO) reported Net Cash Flow of -$171.3 million for Q1 2026, down 12.7% year-over-year from -$196.2 million in Q1 2025, and down 277.51% quarter-over-quarter from $96.5 million in Q4 2025.
Perrigo (PRGO) Net Cash Flow (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Net Cash Flow data on file, last reported at -$171.3 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$171.3 million, down 12.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$76.7 million (up 67.5% YoY), and the FY2025 annual result was -$57.4 million, up 66.1% from the prior year.
- Net Cash Flow eased to -$171.3 million in Q1 2026 per PRGO's latest filing, from $96.5 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $908.2 million in Q3 2024 and troughed at -$1.4 billion in Q3 2022.
- A 5-year average of -$87.5 million and a median of -$4.7 million in 2022 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 1698.42% in 2024 and fell as far as 113500.0% in 2024.
- A 5-year view of Net Cash Flow shows it stood at $117.4 million in 2022, then gained by 20.36% to $141.3 million in 2023, then tumbled by 721.8% to -$878.6 million in 2024, then jumped by 110.98% to $96.5 million in 2025, then slumped by 277.51% to -$171.3 million in 2026.
- Business Quant data shows PRGO's Net Cash Flow at -$171.3 million in Q1 2026, $96.5 million in Q4 2025, and -$20.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 139.49 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -3.97 Mn |
| 10 | Perrigo | 1.61 Bn | 1.25 Bn | 325.50 Mn | -171.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -171.30 Mn |
| Mar 28, 2026 | -171.30 Mn |
| Dec 31, 2025 | 96.50 Mn |
| Dec 31, 2025 | 96.50 Mn |
| Sep 27, 2025 | -20.00 Mn |
| Sep 27, 2025 | -20.00 Mn |
| Jun 28, 2025 | 18.10 Mn |
| Jun 28, 2025 | 18.10 Mn |
| Mar 29, 2025 | -152.00 Mn |
| Mar 29, 2025 | -152.00 Mn |
| Dec 31, 2024 | -878.60 Mn |
| Dec 31, 2024 | -878.60 Mn |
| Sep 28, 2024 | 908.20 Mn |
| Sep 28, 2024 | 908.20 Mn |
| Jun 29, 2024 | -113.60 Mn |
| Jun 29, 2024 | -113.60 Mn |
| Mar 30, 2024 | -85.30 Mn |
| Mar 30, 2024 | -85.30 Mn |
| Dec 31, 2023 | 141.30 Mn |
| Dec 31, 2023 | 141.30 Mn |